Key Insights

Highlights

Success Rate

33% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

30.8%

4 terminated out of 13 trials

Success Rate

33.3%

-53.2% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results33% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (5)
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Unknown4
Terminated4
Completed2
Not Yet Recruiting1
Recruiting1
Withdrawn1

Trial Success Rate

33.3%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (13)

Research Network

Activity Timeline